Group 6 Copy 52
2
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can immune cells prevent 3D printed blood vessels from falling apart?

Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...

Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?

Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...

Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function

Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...

Backer Badge Funded